Table of Contents
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5 GLOBAL MIGRAINE MARKET, BY TYPES
5.1 EPISODIC
5.2 CHRONIC
6. GLOBAL MIGRAINE MARKET, BY TREATMENT TYPE
6.1 ABORTIVE
6.2 PREVENTIVE
7. GLOBAL MIGRAINE MARKET, BY DRUG CLASS
7.1 TRIPTANS
7.3 ERGOTS
7.3 OTHERS
8. GLOBAL MIGRAINE MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 INTRODUCTION
8.2 EUROPE
82.1 INTRODUCTION
8.3 ASIA-PACIFIC
8.3.1 INTRODUCTION
8.4 MIDDLE EAST & AFRICA
8.4.1 INTRODUCTION
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MIGRAINE MARKET PLAYERS
9..1.1 STRATEGIC PARTNERSHIP
9..1.2 MERGER & ACQUISITION
10 COMPANY PROFILE
10.1 ALLERGAN
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 ABBOTT LABORATORIES
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 GLAXOSMITHKLINE PLC
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 STRATEGY
10.3.5 KEY DEVELOPMENT
10.4 JOHNSON & JOHNSON
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 PFIZER, INC.
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 OTHERS
List of Tables
TABLE 1 GLOBAL MIGRAINE MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 2 GLOBAL MIGRAINE MARKET, BY TREATMENT TYPE, 2023-2030 (USD MILLION)
TABLE 3 GLOBAL MIGRAINE MARKET BY DRUG CLASS 2023-2030 (USD MILLION)
TABLE 4 GLOBAL MIGRAINE MARKET, BY REGION 2023-2030 (USD MILLION)
List of Figures
FIGURE 1 MIGRAINE MARKET RESEARCH PROCESS
FIGURE 2 MIGRAINE MARKET PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL MIGRAINE MARKET, BY TYPE
FIGURE 4 GLOBAL MIGRAINE MARKET, BY TREATMENT TYPE
FIGURE 5 GLOBAL MIGRAINE MARKET, BY DRUG CLASS
FIGURE 6 GLOBAL MIGRAINE MARKET, BY REGIONS
FIGURE 7 GLOBAL MIGRAINE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)